Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway.
Xiongwei Zhu; George Perry; Mark A Smith (Profiled Authors: Smith, Mark A; Zhu, Xiongwei; Perry, George)
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. xxz12@po.cwru.edu
Redox report : communications in free radical research 2003;8(3):129-33.
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease that mainly affects motor neurons. Despite intensive research efforts inspired by the mile-stone discovery linking the Cu/Zn superoxide dismutase 1 (SOD1) gene to a subset of familial cases, the mechanisms underlying disease pathogenesis are still largely unknown. Nonetheless, the recent finding of a second gene associated with familial form of the disease, ALS2, is likely to be of great help in elucidating the key pathways involved in motor neuron degeneration. Here, we provide evidence that the JNK/SAPK pathway plays a critical neuroprotective role in susceptible motor neurons in ALS. The involvement of the JNK/SAPK pathway integrates our knowledge about these two known genetic factors into a single pathogenic pathway involved in both sporadic and familial ALS.
1 Originating Grant
-
1.
Smith, Mark A
METABOLIC ABNORMALITIES IN ALZHEIMER DISEASE
1 May 1999 - 30 April 2006
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 750,386
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
Price, Donald L
MECHANISMS OF MOTOR NEURON DISEASE
15 January 1998 - 31 December 2001
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 1,629,618
-
2.
Lansbury, Peter T
A High-Throughput Assay-SOD1 Aggregation Inhibitors(RMI)
30 September 2005 - 31 August 2006
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 218,750
-
3.
MATTSON, MARK
Apoptosis In Neurodegenerative Disorders
NATIONAL INSTITUTE ON AGING
Total Funding: $ 2,357,366
Related Publications
-
1.
2005John P Crow; Noel Y Calingasan; Junyu Chen; Julie Lynch Hill; M Flint Beal
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice.
Annals of neurology 2005;58(2):258-65. -
2.
2005Huaibin Cai; Xian Lin; Chengsong Xie; Fiona M Laird; Chen Lai; Hongjin Wen; Hsueh-Cheng Chiang; Hoon Shim; Mohamed H Farah; Ahmet Hoke; et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(33):7567-74. -
3.
2002Benoit I Giasson; Deepak M Sampathu; Christina A Wilson; Vanessa Vogelsberg-Ragaglia; Walter E Mushynski; Virginia M-Y Lee
The environmental toxin arsenite induces tau hyperphosphorylation.
Biochemistry 2002;41(51):15376-87.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
544









-
415









-
610









-
540









-
252









-
784










